Hepion Pharmaceuticals, Inc. Common Stock

$0.0880
+0.0164 (+22.91%)

Volume:

7.467K ($657.10)

Market Capitalization:

-

Hepion Pharmaceuticals Price Chart

Hepion Pharmaceuticals Price Chart8:49 AM10:09 AM11:29 AM12:49 PM2:09 PM3:29 PM4:49 PM0.09480.09150.08820.08490.08160.07830.07

Hepion Pharmaceuticals Volume Chart

Hepion Pharmaceuticals Volume Chart8:49 AM10:09 AM11:29 AM12:49 PM2:09 PM3:29 PM4:49 PM3.00K2.57K2.14K1.71K1.29K857429

Hepion Pharmaceuticals Market Segments

After Hours

*No Trades in Segment

Regular Trading Hours

+0.0130(+17.33%)
Open$0.0750
Close$0.0880
Low$0.0750
Low Change0.0000 (0.00%)
High$0.0948
High Change+0.0198 (+26.44%)
Range$0.0198
Volume7.467K
Dollar Volume$657.10

Premarket

*No Trades in Segment

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

-0.0140(-16.36%)
Open$0.0856
Close$0.0716
Low$0.0716
Low Change-0.0140 (-16.36%)
High$0.0880
High Change+0.0024 (+2.80%)
Range$0.0164
Volume1.937K
Dollar Volume$138.69

Premarket Yesterday

*No Trades in Segment

Hepion Pharmaceuticals Moving Averages

5 Day Moving Average (SMA5)$0.0879
10 Day Moving Average (SMA10)$0.0740
20 Day Moving Average (SMA20)$0.0643
50 Day Moving Average (SMA50)$0.0558
100 Day Moving Average (SMA100)$0.0548
200 Day Moving Average (SMA200)$0.0599

Hepion Pharmaceuticals Statistics

Average Volume (30 Days)32.33K
P/E Ratio (Current)-.06
EPS (Current)-$1.50
Dividend Yield0.00%
Free Cash Flow
Cash Ratio4.90
Current Ratio6.75
Quick Ratio6.75
Debt to Equity0.14
Enterprise Value-$3.08M
EV to EBITDA0.20
EV to Sales
Price to Book0.25
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-2.60%
Return on Equity-4.22%

Hepion Pharmaceuticals Stock Splits

There have been 4 stock splits for Hepion Pharmaceuticals (HEPA). The last reverse stock split occured on March 18, 2025 and reduced the outstanding shares at a ratio of 50:1.

DateTypeRatio
Mar 18, 2025Reverse50:1
May 11, 2023Reverse20:1
Jun 3, 2019Reverse70:1
May 29, 2018Reverse8:1

Hepion Pharmaceuticals Dividends

There have been no dividends for Hepion Pharmaceuticals (HEPA).